Hopital Prive Dijon Bourgogne

The department focuses on chronic limb threatening ischemia in patients undergoing distal revascularization, evaluating whether extended dual anti‑platelet therapy can improve amputation‑free survival and overall mortality.

• Duration of antiplatelet treatment after endovascular procedures
• Limb salvage and functional outcomes
• Integration of anticoagulant background therapy
• Patient safety and bleeding risk assessment

These investigations are conducted at Hopital Prive Dijon Bourgogne, contributing to advances in vascular surgery across Europe.

The site is studying influenza‑induced acute hypoxemic respiratory failure, comparing the impact of early corticosteroid therapy on mortality, ventilator dependence, and intensive‑care stay.

• Early intervention strategies for severe influenza
• Effect on ventilator‑free and ICU‑free days
• Safety profile of systemic steroids in viral pneumonia
• Outcome measures for critical respiratory illness

This work reinforces the hospital’s role in respiratory medicine research within the French healthcare network.